Malignant Lymphomas |
1 Institute of Pathology, Eberhard-Karls-University of Tübingen, Tübingen, Germany
2 Institute of Pathology, Technical University Munich, Munich Germany
3 Department of Clinical Pathology, Hematopathology Section, Cleveland Clinic, Cleveland, USA
4 Department of Pathology, CHU Sart Tilman, University of Liege, Liege, Belgium
5 Institutes of Pathology
6 Human Genetics, Christian-Albrechts-University Kiel & University Hospital Schleswig-Holstein, Campus Kiel, Germany
Correspondence: Leticia Quintanilla-Martinez, M.D., Eberhard-Karls-University of Tübingen, Institute of Pathology, Liebermeisterstrasse 8, 72076 Tübingen, Germany. E-mail:leticia.quintanilla-fend{at}med.uni-tuebingen.de
Mantle cell lymphoma is characterized by the t(11;14) chromosomal translocation, resulting in the overexpression of cyclin D1 (CycD1). Recently, cases of mantle cell lymphoma negative for cycD1 but positive for cycD2 or cycD3 were identified by gene expression profiling and confirmed by immunohistochemistry. We analyzed 4 cases of cycD2+ mantle cell lymphoma with a translocation involving the CCND2 locus, and its differential diagnosis from 35 mature B-cell non-Hodgkins lymphomas based on immunohistochemistry, quantitative RT-PCR and FISH analysis. Bona fide cycD2+ mantle cell lymphoma carried translocations involving the CCND2 gene, and IGH and IGK loci were identified as partners. As a result of this translocation, cycD2 mRNA was highly over-expressed when compared with normal lymphoid tissue and other B-cell non-Hodgkins lymphomas, including chronic lymphocytic leukemia, making this technique ideally suited to identify cycD2+mantle cell lymphoma. In contrast, positive immunostaining for cycD2 was found in most B-cell non-Hodgkins lymphomas, and therefore, it is not specific for a diagnosis of cycD2+mantle cell lymphoma.
Key words: cyclin D2+, mantle cell lymphoma (MCL), FISH, QRT-PCR.
Related Article
Haematologica 2009 94: 1488-1492.
This article has been cited by other articles:
![]() |
S. A. Pileri and B. Falini Mantle cell lymphoma Haematologica, November 1, 2009; 94(11): 1488 - 1492. [Full Text] [PDF] |
||||